IDEXX Laboratories (IDXX)
Provides veterinary diagnostics, reference laboratories, and practice software for connected clinical workflows.
$518.07
vs last close−3.43 (−0.66%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
$3.71
Revenue estimate
$1.19B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$2.62$2.96$3.63$3.40$3.08$3.47$4.27Pending
Estimate$2.39$2.85$3.28$3.14$2.93$3.41$3.94$3.71
Surprise+9.6%+3.9%+10.7%+8.3%+5.1%+1.8%+8.4%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$954.3M$998.4M$1.11B$1.11B$1.09B$1.14B$1.22BPending
Estimate$935.1M$997.1M$1.06B$1.07B$1.07B$1.12B$1.20B$1.19B
Surprise+2.0%+0.1%+4.4%+3.0%+1.7%+2.0%+1.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2029 | $4.57 | — | — |
| Dec 2028 | $4.50 | — | — |
| Sep 2028 | $4.89 | — | — |
| Jun 2028 | $5.42 | — | — |
| Mar 2028 | $4.22 | — | — |
| Dec 2027 | $3.95 | — | — |
| Sep 2027 | $4.29 | — | — |
| Jun 2027 | $4.63 | — | — |
| Mar 2027 | $3.98 | — | — |
| Dec 2026 | $3.39 | — | — |
| Nov 2026 | $3.71 | — | — |
| Aug 2026 | $3.94 | $4.27 | +8.4% |
| May 2026 | $3.41 | $3.47 | +1.8% |
| Feb 2026 | $2.93 | $3.08 | +5.1% |
| Nov 2025 | $3.14 | $3.40 | +8.3% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2029 | $4.57 | — | — | $1.37B | — | — | — |
| Dec 2028 | $4.50 | — | — | $1.38B | — | — | — |
| Sep 2028 | $4.89 | — | — | $1.43B | — | — | — |
| Jun 2028 | $5.42 | — | — | $1.46B | — | — | — |
| Mar 2028 | $4.22 | — | — | $1.29B | — | — | — |
| Dec 2027 | $3.95 | — | — | $1.27B | — | — | — |
| Sep 2027 | $4.29 | — | — | $1.30B | — | — | — |
| Jun 2027 | $4.63 | — | — | $1.32B | — | — | — |
| Mar 2027 | $3.98 | — | — | $1.23B | — | — | — |
| Dec 2026 | $3.39 | — | — | $1.17B | — | — | — |
| Nov 2, 2026 | $3.71 | — | — | $1.19B | — | — | — |
| Aug 4, 2026 | $3.94 | $4.27 | +8.4% | $1.20B | $1.22B | +1.4% | +3.6% |
| May 5, 2026 | $3.41 | $3.47 | +1.8% | $1.12B | $1.14B | +2.0% | −0.0% |
| Feb 2, 2026 | $2.93 | $3.08 | +5.1% | $1.07B | $1.09B | +1.7% | −4.6% |
| Nov 3, 2025 | $3.14 | $3.40 | +8.3% | $1.07B | $1.11B | +3.0% | +14.8% |
| Aug 4, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 3, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 5, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Feb 6, 2023 | |||||||
| Nov 1, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 2, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Jul 30, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 2, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 31, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Jan 31, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 1, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 4, 2018 | |||||||
| Feb 1, 2018 | |||||||
| Oct 31, 2017 | |||||||
| Aug 1, 2017 | |||||||
| Apr 28, 2017 | |||||||
| Feb 2, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 2, 2016 | |||||||
| Apr 29, 2016 | |||||||
| Jan 29, 2016 | |||||||
| Oct 28, 2015 | |||||||
| Jul 30, 2015 |